デフォルト表紙
市場調査レポート
商品コード
1619296

臨床化学分析装置の市場規模、シェア、成長分析、製品別、検査タイプ別、地域別- 産業予測、2024~2031年

Clinical Chemistry Analyzers Market Size, Share, Growth Analysis, By Product (Reagents, Analyzers), By Test Type (Basic Metabolic Panels, Liver Panels), By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 157 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
臨床化学分析装置の市場規模、シェア、成長分析、製品別、検査タイプ別、地域別- 産業予測、2024~2031年
出版日: 2024年12月18日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

臨床化学分析装置の世界市場規模は、2022年に128億米ドルと評価され、2023年の134億5,000万米ドルから2031年には200億2,000万米ドルに成長し、予測期間(2024~2031年)のCAGRは5.1%で成長する見通しです。

世界の臨床化学分析装置市場は、診断検査の需要の高まりと慢性疾患の有病率の増加によって大きく成長しています。これらの分析装置は、生体サンプル中の化学成分を測定する上で重要であり、特に高齢者人口の増加により糖尿病や心血管疾患などの罹患率が高まっています。強化されたアルゴリズムや自動化を含む技術的進歩により、精度と効率はさらに向上し、普及が進んでいます。しかし、初期費用やメンテナンス費用が高いなどの課題により、特に発展途上地域の小規模検査室では利用が制限される可能性があります。さらに、検査プロセスの複雑さと規制要件の厳しさにより、熟練した人材と品質基準の遵守が必要となり、利害関係者の市場情勢を複雑にしています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次データと一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーター分析と影響
    • 競争企業間の敵対関係
    • 代替品の脅威
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 供給企業の交渉力

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2023年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 技術の進歩
  • 規制情勢
  • ケーススタディ

臨床化学分析装置の市場規模:製品別& CAGR(2024-2031)

  • 試薬
    • キャリブレーター
    • コントロール
    • 標準
    • その他
  • 分析装置
    • 小型
    • 中型
    • 大型
    • 特大型
  • その他の製品

臨床化学分析装置の市場規模:検査タイプ別& CAGR(2024-2031)

  • 基礎代謝パネル
  • 肝臓パネル
  • 腎臓パネル
  • 脂質プロファイル
  • 甲状腺機能パネル
  • 電解質パネル
  • 特殊化学検査

臨床化学分析装置の市場規模:エンドユーザー別& CAGR(2024-2031)

  • 病院と診療所
  • 診断検査室
  • 研究室・研究機関
  • その他のエンドユーザー

臨床化学分析装置の市場規模:地域別& CAGR(2024-2031)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 市場の最近の動向
  • 企業の市場シェア分析(2023年)
  • 主要企業の企業プロファイル
    • 会社概要
    • 製品ポートフォリオ分析
    • セグメント別シェア分析
    • 収益の前年比比較(2021-2023)

主要企業プロファイル

  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation(Beckman Coulter)
  • Abbott
  • Siemens Healthineers AG
  • F. Hoffmann-La Roche Ltd
  • HORIBA, Ltd.
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd
  • Hitachi Ltd.
  • EKF Diagnostics
  • Sysmex Corporation
  • Mindray Medical International
  • Biobase Group
  • SFRI
  • Trivitron Healthcare Pvt. Ltd.
  • Randox Laboratories Ltd
  • Medica Corporation

結論と推奨事項

目次
Product Code: SQMIG35A2667

Global Clinical Chemistry Analyzers Market size was valued at USD 12.8 billion in 2022 and is poised to grow from USD 13.45 billion in 2023 to USD 20.02 billion by 2031, growing at a CAGR of 5.1% during the forecast period (2024-2031).

The global clinical chemistry analyzers market has seen substantial growth, largely fueled by rising diagnostic test demand and the increasing prevalence of chronic diseases. These analyzers are critical in measuring chemical components in biological samples, especially as the elderly population grows, leading to heightened incidences of conditions like diabetes and cardiovascular diseases. Technological advancements, including enhanced algorithms and automation, have further improved their accuracy and efficiency, promoting wider adoption. However, challenges such as high initial and maintenance costs can restrict access for smaller laboratories, particularly in developing regions. Additionally, the complexity of the testing process and stringent regulatory requirements necessitate skilled personnel and adherence to quality standards, complicating the market landscape for stakeholders.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Chemistry Analyzers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Chemistry Analyzers Market Segmental Analysis

Global Clinical Chemistry Analyzers Market is segmented by Product, Test Type, End User and Region. Based on Product, the market is segmented into Reagents, Analyzers, Other Products. Based on Test Type, the market is segmented into Basic Metabolic Panels, Liver Panels, Renal Panels, Lipid Profiles, Thyroid Function Panels, Electrolyte Panels, Specialty Chemical Tests. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Laboratories, Research Laboratories & Institutes, Other End Users. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa.

Driver of the Global Clinical Chemistry Analyzers Market

One of the primary catalysts for growth in the Global Clinical Chemistry Analyzers market is the surging prevalence of chronic diseases, including diabetes, cardiovascular ailments, and renal disorders. As these health issues become more widespread, there is an increased need for accurate diagnostics and ongoing monitoring, which clinical chemistry analyzers facilitate. These sophisticated devices are essential for testing and analyzing biological samples, thereby enhancing the ability to track disease progression and treatment efficacy. Consequently, the escalating incidence of these conditions significantly fuels the demand for advanced clinical chemistry analyzers, marking a pivotal trend in the market's development.

Restraints in the Global Clinical Chemistry Analyzers Market

The global clinical chemistry analyzers market faces significant constraints due to stringent regulatory requirements and quality control measures. Adhering to these regulations can prove to be complex and time-consuming, which adds to the overall costs associated with product development and commercialization. Manufacturers often encounter challenges in navigating the regulatory landscape, leading to delays in bringing new products to market. Consequently, the intricate compliance process can hinder innovation and result in increased financial burdens, ultimately stifling growth potential within the clinical chemistry analyzers sector. These challenges underline the need for efficient strategies to streamline compliance efforts while ensuring product safety and efficacy.

Market Trends of the Global Clinical Chemistry Analyzers Market

The Global Clinical Chemistry Analyzers market is witnessing a significant trend towards point-of-care testing (POCT), fueled by the rising demand for rapid diagnostic results and the shift towards decentralized testing environments. As healthcare systems increasingly prioritize timely decision-making, compact and portable clinical chemistry analyzers are being embraced for their capability to facilitate on-site testing. This trend enhances the efficiency of healthcare delivery, enabling providers to promptly diagnose and treat conditions, thereby improving patient outcomes. The growing emphasis on personalized medicine and efficient healthcare services further bolsters the expansion of POCT, positioning it as a key driver of market growth in the clinical chemistry sector.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Regulatory Landscape
  • Case Studies

Global Clinical Chemistry Analyzers Market Size by Product & CAGR (2024-2031)

  • Reagents
    • Calibrators
    • Controls
    • Standards
    • Others
  • Analyzers
    • Small
    • Medium
    • Large
    • Very Large
  • Other Products

Global Clinical Chemistry Analyzers Market Size by Test Type & CAGR (2024-2031)

  • Basic Metabolic Panels
  • Liver Panels
  • Renal Panels
  • Lipid Profiles
  • Thyroid Function Panels
  • Electrolyte Panels
  • Specialty Chemical Tests

Global Clinical Chemistry Analyzers Market Size by End User & CAGR (2024-2031)

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Research Laboratories & Institutes
  • Other End Users

Global Clinical Chemistry Analyzers Market Size by Region & CAGR (2024-2031)

  • North America, (by Product, by Test Type, by End User)
    • US
    • Canada
  • Europe, (by Product, by Test Type, by End User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (by Product, by Test Type, by End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (by Product, by Test Type, by End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (by Product, by Test Type, by End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (Beckman Coulter)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HORIBA, Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QuidelOrtho Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Randox Laboratories Ltd
  • Hitachi Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EKF Diagnostics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sysmex Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mindray Medical International
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biobase Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SFRI
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Trivitron Healthcare Pvt. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Randox Laboratories Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medica Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation